Weihai Baihe Biology Technological Co., Ltd. (SHA:603102)

Market Cap	2.35B -14.2%
Revenue (ttm)	994.19M +22.8%
Net Income	118.63M -7.5%
EPS	1.93 -3.8%
Shares Out	62.27M
PE Ratio	19.61
Forward PE	n/a
Dividend	0.75 (1.89%)
Ex-Dividend Date	Aug 27, 2026

Volume	5,925,600
Open	39.18
Previous Close	39.72
Day's Range	36.76 - 40.94
52-Week Range	30.46 - 51.84
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About SHA:603102

Weihai Baihe Biology Technological Co., Ltd., together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food products in China and internationally. The company offers health food; nutritious food for feminine glamour, male energy, elderly care, pregnancy, babies, and childcare, as well as nutritional soft candies; special diet products comprising supplementary food and nutritional supplements, nutritional supplements for pregnant wome...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 1,096
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603102

Financial Performance

In 2025, SHA:603102's revenue was 910.93 million, an increase of 13.67% compared to the previous year's 801.40 million. Earnings were 128.43 million, a decrease of -7.81%.

Data Sources: S&P Global Market Intelligence and Alpha Vantage

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Alpha Vantage.

Last checked:

Aug 25, 2026

Data Sources Report a data error